Evidence map›Paper›PMID 25966952›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2015

The effects of delayed reduction of tonic inhibition on ischemic lesion and sensorimotor function.

Evelyn M R Lake, Joydeep Chaudhuri, Lynsie Thomason, Rafal Janik, Milan Ganguly, Mary Brown, JoAnne McLaurin, Dale Corbett, Greg J Stanisz, Bojana Stefanovic

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Astrocytic BEST1 can serve as a target for functional recovery after ischemic stroke.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. The Excessive Tonic Inhibition of the Peri-infarct Cortex Depresses Low Gamma Rhythm Power During Poststroke Recovery.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  4. TRPM2 and CaMKII Signaling Drives Excessive GABAergic Synaptic Inhibition Following Ischemia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Article
  6. Review
  7. The Gliopeptide ODN, a Ligand for the Benzodiazepine Site of GABAThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  8. Article
  9. Basmisanil, a highly selective GABAScientific reports · 2021
    Article
  10. Targeting GABABrain sciences · 2021
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Preclinical concepts and results with the GABANeural regeneration research · 2019
    Article
  18. Transcranial Direct Current Stimulation Modulates GABA Levels Beyond the Stimulated Region: Perspectives for Stroke Rehabilitation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  19. Review
  20. GAT3 selective substrate l-isoserine upregulates GAT3 expression and increases functional recovery after a focal ischemic stroke in mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Evelyn M R LakeDepartment of Medical Biophysics, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Joydeep ChaudhuriDepartment of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Lynsie ThomasonDepartment of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Rafal JanikDepartment of Medical Biophysics, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Milan GangulyDepartment of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Mary BrownDepartment of Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
JoAnne McLaurinDepartment of Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Dale CorbettDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Greg J StaniszDepartment of Medical Biophysics, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Bojana StefanovicDepartment of Medical Biophysics, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
University of Toronto · CASunnybrook Research InstituteHealth Sciences Centre · CASunnybrook Health Science Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To aid in development of chronic stage treatments for sensorimotor deficits induced by ischemic stroke, we investigated the effects of GABA antagonism on brain structure and fine skilled reaching in a rat model of focal ischemia induced via cortical microinjections of endothelin-1 (ET-1). Beginning 7 days after stroke, animals were administered a gamma-aminobutyric acid (GABAA) inverse agonist, L-655,708, at a dose low enough to afford α5-GABAA receptor specificity. A week after stroke, the ischemic lesion comprised a small hypointense necrotic core (6±1 mm(3)) surrounded by a large (62±11 mm(3)) hyperintense perilesional region; the skilled reaching ability on the Montoya staircase test was decreased to 34%±2% of the animals' prestroke performance level. On L-655,708 treatment, animals showed a progressive decrease in total stroke volume (13±4 mm(3) per week), with no change in animals receiving placebo. Concomitantly, treated animals' skilled reaching progressively improved by 9%±1% per week, so that after 2 weeks of treatment, these animals performed at 65%±6% of their baseline ability, which was 25%±11% better than animals given placebo. These data indicate beneficial effects of delayed, sustained low-dose GABAA antagonism on neuroanatomic injury and skilled reaching in the chronic stage of stroke recovery in an ET-1 rat model of focal ischemia.

Indexed as

AnimalsBehavior, AnimalBrain IschemiaEndothelin-1GABA AntagonistsHeart RateImidazolesMaleMotor SkillsNecrosisOxygen ConsumptionRatsRats, Sprague-DawleyReceptors, GABA-ARecovery of FunctionRespiratory RateEndothelin-1GABA AntagonistsImidazolesL 655,708Receptors, GABA-A

Identifiers

PMID25966952
PMCPMC4640317
OpenAlexW2209939627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.